Home Launch

Launch

Dr. Reddy’s Laboratories announces the launch of Fosaprepitant for Injection in the U.S. Market

Dr. Reddy’s Laboratories announces the launch of Fosaprepitant for Injection in the U.S. Market

Hyderabad, September 14, 2019: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Fosaprepitant for Injection, the therapeutic generic equivalent of EMEND® (fosaprepitant)...